Skip to main content Skip to main navigation menu Skip to site footer
Subscription Contact the editors
  • en
  • ru
REMEDIUM
ISSN 1561-5936 (Print)
ISSN 2658-3534 (Online)
  • Current
  • Archive
  • About
    • About the Journal
    • Author Guidelines
    • Editorial Masthead
    • Privacy Statement
  • Editorial Board
  • Contact
  • Register
  • Login
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

Found one item.
  • Investment activity and financial results of pharmaceutical companies: intermediate results of 2019

    Romanova S.
    62-69
    2019-12-15
    Abstract
    The analysis of investment activity of pharmaceutical industry enterprises was carried out according to the data of the state statistical reporting form No. P-2 «Information on Investments in Non-Financial Assets». Investments in fixed capital of enterprises in various sectors of the economy by type of activity with the OKVED221 code: «Production of medicines and materials used for medical purposes» in the first half of 2019 in Russia amounted to 18.609 billion rubles, which is 1.84 times higher than the previous year. In the first half of 2019, pharmaceutical companies with the OKVED221 code invested 18.595 billion rubles in fixed assets. The source of these investments was mainly own funds of the industry enterprises - 15.476 billion rubles, or 83.23% of the total amount. The main source of funds raised was bank loans - 1.922 billion rubles, or 61.62%, as well as borrowings from other organizations - 0.505 billion rubles, or 16.19% of the total amount of funds raised. It is possible to assess the financial condition of the industry enterprises by the level of financial stability and solvency, which are characterized by appropriate coefficients. Let's consider in general for the industry the values of the coefficients that characterize: a) financial stability: the ratio of borrowed and own funds, the coefficient of autonomy, the coefficient of maneuverability and the coefficient of own funds availability, b) solvency: the coefficient of absolute liquidity, the liquidity ratio and the coverage ratio. As the results of the analysis of the financial condition of pharmaceutical industry enterprises have shown, all the coefficients that characterize the level of financial stability and solvency of the industry enterprises were within the normative values. The only exception was the absolute liquidity and coverage coefficients, which turned out to be lower than the normative level.
1 - 1 of 1 items

Главный редактор

Editor-in-chief

 

 

Khabriev Ramil

Make a Submission

Make a Submission

Information

  • For Readers
  • For Authors
  • For Librarians

Latest publications

  • Atom logo
  • RSS2 logo
  • RSS1 logo

Mailing address

Адрес: 105064, г. Москва, ул. Воронцово Поле, д. 12, стр. 1

Email: redactor@remedium-journal.ru

Телефон: +7(495) 917-48-86

Editorial office

Шерстнева Елена Владимировна
FSSBI «N.A. Semashko National Research Institute of Public Health»

E-mail:

© 2026 Journal «REMEDIUM»